✦ LIBER ✦

Efficacy and safety of donepezil in patients with Alzheimer's disease: preliminary findings from the Australian subset of a global clinical experience study

✍ Scribed by H. Brodaty; R. Bahra; R. Zhang; M. O'Leary; K. Short; M. Barrington

Book ID: 119574932
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 10
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(00)80490-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of donepezil on cognition and fu

Effects of donepezil on cognition and functional ability in patients with Alzheimer's disease: Preliminary findings from the Australian subset of a global clinical experience study

✍ Ranbir Bahra; Henry Brodaty; Richard Zhang; Kym Short; Michelle Barrington 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Effects of donepezil on patient health-r

Effects of donepezil on patient health-related quality of life and caregiver perception in Alzheimer's disease: Preliminary findings from the Australian subset of a global clinical experience study

✍ Majella O'Leary; Henry Brodaty; Ranbir Bahra; Richard Zhang 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Efficacy and safety of donepezil in pati

Efficacy and safety of donepezil in patients with dementia with Lewy bodies: Preliminary findings from an open-label study

✍ SATORU MORI; ETSURO MORI; EIZO ISEKI; KENJI KOSAKA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Efficacy and safety of donepezil over 3

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease

✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##

A safety, tolerability and pharmacokinet

A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil

✍ Pierre Tariot; Marwan Sabbagh; Stephen Flitman; Patricio Reyes; Louise Taber; Ly 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and safety of donepezil in pati

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi